CN Patent

CN110139651A — 用于治疗阿片样物质过量的组合物和方法

Assigned to Yingliwei Co · Expires 2019-08-16 · 7y expired

What this patent protects

提供了适于经鼻递送的药物产品，其包括填充有包含纳美芬的药物组合物的预先引发的装置。还提供了用该药物产品治疗阿片样物质过量的方法。

USPTO Abstract

提供了适于经鼻递送的药物产品，其包括填充有包含纳美芬的药物组合物的预先引发的装置。还提供了用该药物产品治疗阿片样物质过量的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110139651A
Jurisdiction
CN
Classification
—
Expires
2019-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Yingliwei Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.